glp-1 medications pros and cons Part 2 of a 3-Part Series; for Weight Loss 2026 Employee Benefits Trends: Should

Dual and Triple Agonists: The next generation of medications, such as Tirzepatide (which targets both GLP-1 and GIP receptors), are already demonstrating even greater efficacy for weight loss and blood sugar control

The tips below are designed to help you stay ahead of dehydration in realistic, approachable waysso you can feel your best while continuing to make progress on your health goals

Suganuma Y, Shimizu T, Sato T, Morii T, Fujita H, Harada Sassa M et al (2020) Magnitude of slowing gastric emptying by glucagon-like peptide-1 receptor agonists determines the amelioration of postprandial glucose excursion in Japanese patients with type 2 diabetes

van Raalte DH, Bunck MC, Smits MM, Hoekstra T, Corner A, Diamant M, et al

beta-Cell Pdx1 expression is essential for the glucoregulatory, proliferative, and cytoprotective actions of glucagon-like peptide-1